Novel polymorphisms in HLA-DOA and HLA-DOB in B-cell malignancies

Immunogenetics

Volumn 54, Issue 8, 2002, Pages 591-595

  Van Lith, Marcel ^a   Van Ham, Marieke ^b   Neefjes, Jacques ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

B cell leukemia; Celiac disease; Graves disease; Rheumatoid arthritis; Systemic lupus erythematosus

Indexed keywords

AMINO ACID; HLA DO ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTIGEN BINDING; ANTIGEN FUNCTION; ANTIGEN PRESENTING CELL; ANTIGENIC VARIATION; ARTICLE; AUTOIMMUNE DISEASE; B CELL LEUKEMIA; CELIAC DISEASE; CHRONIC LYMPHATIC LEUKEMIA; DNA POLYMORPHISM; GENE MUTATION; GENETIC ASSOCIATION; GENETIC CONSERVATION; GENETIC LINKAGE; GRAVES DISEASE; HLA SYSTEM; HUMAN; NONHUMAN; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

AUTOIMMUNE DISEASES; B-LYMPHOCYTES; GENETIC PREDISPOSITION TO DISEASE; HLA-D ANTIGENS; HUMANS; LEUKEMIA, B-CELL; POLYMORPHISM, GENETIC;

EID: 18744397186     PISSN: 00937711     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00251-002-0500-6     Document Type: Article

References (41)

1. Adams TE, Bodmer JG, Bodmer WF (1983) Production and characterization of monoclonal antibodies recognizing the alpha-chain subunits of human ia alloantigens. Immunology 50:613-624
2. Aluvihare VR, Khamlichi AA, Williams GT, Adorini L, Neuberger MS (1997) Acceleration of intracellular targeting of antigen by the B-cell antigen receptor: Importance depends on the nature of the antigen-antibody interaction. EMBO J 16:3553-3562
3. Amar A, Holbeck SL, Nepom GT (1987) Specific allelic variation among linked HLA class II genes. Transplantation 44:831-835
4. Boes M (2000) Role of natural and immune IgM antibodies in immune responses. Mol Immunol 37:1141-1149
5. Chan OT, Hannum LG, Haberman AM, Madaio MP, Shlomchik MJ (1999a) A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus. J Exp Med 189:1639-1648
6. Chan OT, Madaio MP, Shlomchik MJ (1999b) The central and multiple roles of B cells in lupus pathogenesis. Immunol Rev 169:107-121
7. De Juan D, Martin-Villa JM, Gomez-Reino JJ, Vicario JL, Corell A, Martinez-Laso J, Benmammar D, Arnaiz-Villena A (1993) Differential contribution of C4 and HLA-DQ genes to systemic lupus erythematosus susceptibility. Hum Genet 91:579-584
8. Denzin LK, Cresswell P (1995) HLA-DM induces CLIP dissociation from MHC class II alpha beta dimers and facilitates peptide loading. Cell 82:155-165
9. Douek DC, Altmann DM (1997) HLA-DO is an intracellular class II molecule with distinctive thymic expression. Int Immunol 9:355-364
10. Ham SM van, Gruneberg U, Malcherek G, Broker I, Melms A, Trowsdale J (1996) Human histocompatibility leukocyte antigen (HLA)-DM edits peptides presented by HLA-DR according to their ligand binding motifs. J Exp Med 184:2019-2024
11. Ham SM van, Tjin EP, Lillemeier BF, Gruneberg U, Meijgaarden KE van, Pastoors L, Verwoerd D, Tulp A, Canas B, Rahman D, Ottenhoff TH, Pappin DJ, Trowsdale J, Neefjes J (1997) HLA-DO is a negative modulator of HLA-DM-mediated MHC class II peptide loading. Curr Biol 7:950-957
12. Ham M van, Lith M van, Lillemeier B, Tjin E, Gruneberg U, Rahman D, Pastoors L, Meijgaarden K van, Roucard C, Trowsdale J, Ottenhoff T, Pappin D, Neefjes J (2000) Modulation of the major histocompatibility complex class II-associated peptide repertoire by human histocompatibility leukocyte antigen (HLA)-DO. J Exp Med 191:1127-1136
13. Hirano T (2002) Revival of the autoantibody model in rheumatoid arthritis. Nat Immunol 3:342-344
14. Inoko H, Ando A, Kimura M, Tsuji K (1985) Isolation and characterization of the cDNA clone and genomic clones of a new HLA class II antigen heavy chain, DO alpha. J Immunol 135: 2156-2159
15. Jonsson AK, Rask L (1989) Human class II DNA and DOB genes display low sequence variability. Immunogenetics 29:411-413
16. Karlsson L, Surh CD, Sprent J, Peterson PA (1991) A novel class II MHC molecule with unusual tissue distribution. Nature 351:485-488
17. Kropshofer H, Vogt AB, Moldenhauer G, Hammer J, Blum JS, Hammerling GJ (1996) Editing of the HLA-DR-peptide repertoire by HLA-DM. EMBO J 15:6144-6154
18. Lacroix-Desmazes S, Kaveri SV, Mouthon L, Ayouba A, Malanchere E, Coutinho A, Kazatchkine MD (1998) Self-reactive antibodies (natural autoantibodies) in healthy individuals. J Immunol Methods 216:117-137
19. Larhammar D, Hammerling U, Rask L, Peterson PA (1985) Sequence of gene and cDNA encoding murine major histocompatibility complex class II gene A beta 2. J Biol Chem 260:14111-14119
20. Liljedahl M, Winqvist O, Surh CD, Wong P, Ngo K, Teyton L, Peterson PA, Brunmark A, Rudensky AY, Fung-Leung WP, Karlsson L (1998) Altered antigen presentation in mice lacking H2-O. Immunity 8:233-243
21. Lin RH, Mamula MJ, Hardin JA, Janeway CA Jr (1991) Induction of autoreactive B cells allows priming of autoreactive T cells. J Exp Med 173:1433-1439
22. Maciel LM, Rodrigues SS, Dibbern RS, Navarro PA, Donadi EA (2001) Association of the HLA-DRB1*0301 and HLA-DQA1*0501 alleles with Graves' disease in a population representing the gene contribution from several ethnic backgrounds. Thyroid 11:31-35
23. Mackay IR, Rose NR (2001) Autoimmunity and lymphoma: Tribulations of B cells. Nat Immunol 2:793-795
24. Marrack P, Kappler J, Kotzin BL (2001) Autoimmune disease: Why and where it occurs. Nat Med 7:899-905
25. Mitchell RN, Barnes KA, Grupp SA, Sanchez M, Misulovin Z, Nussenzweig MC, Abbas AK (1995) Intracellular targeting of antigens internalized by membrane immunoglobulin in B lymphocytes. J Exp Med 181:1705-1714
26. Naruse TK, Kawata H, Anzai T, Takashige N, Kagiya M, Nose Y, Nabeya N, Isshiki G, Tatsumi N, Inoko H (1999) Limited polymorphism in the HLA-DOA gene. Tissue Antigens 53: 359-365
27. Nielsen H, Engelbrecht J, Brunak S, Heijne G von (1997) Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites. Protein Eng 10:1-6
28. Sadegh-Nasseri S, Germain RN (1991) A role for peptide in determining MHC class II structure. Nature 353:167-170
29. Sanderson F, Powis SH, Kelly AP, Trowsdale J (1994) Limited polymorphism in HLA-DM does not involve the peptide binding groove. Immunogenetics 39:56-58
30. Schroeder HW, Dighiero G (1994) The pathogenesis of chronic lymphocytic leukemia: Analysis of the antibody repertoire. Immunol Today 15:288-294
31. Servenius B, Rask L, Peterson PA (1987) Class II genes of the human major histocompatibility complex. The DO beta gene is a divergent member of the class II beta gene family. J Biol Chem 262:8759-8766
32. Sherman MA, Weber DA, Jensen PE (1995) DM enhances peptide binding to class II MHC by release of invariant chain-derived peptide. Immunity 3:197-205
33. Siemasko K, Eisfelder BJ, Williamson E, Kabak S, Clark MR (1998) Cutting edge: Signals from the B lymphocyte antigen receptor regulate MHC class II containing late endosomes. J Immunol 160:5203-5208
34. Sobel ES, Kakkanaiah VN, Kakkanaiah M, Cheek RL, Cohen PL, Eisenberg RA (1994) T-B collaboration for autoantibody production in lpr mice is cognate and MHC-restricted. J Immunol 152:6011-6016
35. Sollid LM (2000) Molecular basis of celiac disease. Annu Rev Immunol 18:53-81
36. Spurkland A, Sollid LM, Ronningen KS, Bosnes V, Ek J, Vartdal F, Thorsby E (1990) Susceptibility to develop celiac disease is primarily associated with HLA-DQ alleles. Hum Immunol 29:157-165
37. Tonnelle C, DeMars R, Long EO (1985) DO beta: a new beta chain gene in HLA-D with a distinct regulation of expression. EMBO J 4:2839-2847
38. Trowsdale J, Kelly A (1985) The human HLA class II alpha chain gene DZ alpha is distinct from genes in the DP, DQ and DR subregions. EMBO J 4:2231-2237
39. Tusnady GE, Simon I (1998) Principles governing amino acid composition of integral membrane proteins: Application to topology prediction. J Mol Biol 283:489-506
40. Weetman AP (2001) Determinants of autoimmune thyroid disease. Nat Immunol 2:769-770
41. Zanelli E, Huizinga TW, Guerne PA, Vischer TL, Tiercy JM, Verduyn W, Schreuder GM, Breedveld FC, Vries RR de (1998) An extended HLA-DQ-DR haplotype rather than DRB1 alone contributes to RA predisposition. Immunogenetics 48:394-401